Profiel
Mark E.
Platt is currently the President, Chief Executive Officer & Director at Makana Therapeutics, Inc. Prior to his current position, he served as the Chief Executive Officer at Recombinetics, Inc. from 2019 to 2021.
Mark also held the position of President & Chief Executive Officer at Multistack LLC from 1995 to 2013.
He obtained his undergraduate degree from Vanderbilt University.
Actieve functies van Mark E. Platt
| Bedrijven | Functie | Begin |
|---|---|---|
Makana Therapeutics, Inc.
Makana Therapeutics, Inc. BiotechnologyHealth Technology Develops swine transplantation of cells, tissues and organs from animals | Algemeen Directeur | - |
Eerdere bekende functies van Mark E. Platt
| Bedrijven | Functie | Einde |
|---|---|---|
Recombinetics, Inc.
Recombinetics, Inc. BiotechnologyHealth Technology Develops therapeutic applications for gene editing | Algemeen Directeur | 18-01-2021 |
Multistack LLC
Multistack LLC Industrial MachineryProducer Manufacturing Manufactures and distributes chillers and cooling products | Algemeen Directeur | 01-10-2013 |
Opleiding van Mark E. Platt
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Recombinetics, Inc.
Recombinetics, Inc. BiotechnologyHealth Technology Develops therapeutic applications for gene editing | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Multistack LLC
Multistack LLC Industrial MachineryProducer Manufacturing Manufactures and distributes chillers and cooling products | Producer Manufacturing |
Makana Therapeutics, Inc.
Makana Therapeutics, Inc. BiotechnologyHealth Technology Develops swine transplantation of cells, tissues and organs from animals | Health Technology |
















